Bryder David, Sasaki Yutaka, Borge Ole Johan, Jacobsen Sten-Eirik W
Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden.
J Immunol. 2004 Feb 1;172(3):1548-52. doi: 10.4049/jimmunol.172.3.1548.
Hemopoietic stem cells (HSC) are identified through their unique ability, at the single cell level, to long-term reconstitute all blood cell lineages. Sustained myeloid reconstitution is considered the hallmark of HSC, because myeloid progenitors and their progeny have very short half-lives. Here we demonstrate that the established practice of relying on RB6-8C5 as a myeloid specific Ab can result in overestimation of HSC frequencies because the RB6-8C5 Ab also detects Ags expressed on a sizeable population of CD3(+)CD8(+) T cells, constitutively as well as following transplantation. Likewise, a high fraction of mice transplanted with limiting numbers of ex vivo expanded Lin(-)Sca(+)kit(+)CD34(-) HSC show long-term RB6-8C5(+)CD3(+) (lymphoid) but no RB6-8C5(+)CD3(-) (myeloid) reconstitution. Most noteworthy, the use of RB6-8C5 as a myeloid specific Ab can be deceptive by implicating the existence of lineage-restricted HSC capable of long-term reconstituting the myeloid and T, but not B, cell lineage. Because cross-lineage expression of "lineage-specific" markers is unlikely to be unique to the blood system, claims of unexpected cell fates should be substantiated not only by acquisition of lineage-specific markers, but also absence of markers of other lineages normally derived from the investigated stem cells.
造血干细胞(HSC)通过其在单细胞水平上长期重建造血所有细胞谱系的独特能力得以识别。持续的髓系重建被认为是HSC的标志,因为髓系祖细胞及其后代的半衰期非常短。在此我们证明,依赖RB6-8C5作为髓系特异性抗体的既定做法可能导致对HSC频率的高估,因为RB6-8C5抗体也能检测到大量CD3(+)CD8(+) T细胞上组成性表达以及移植后表达的抗原。同样,用有限数量的体外扩增的Lin(-)Sca(+)kit(+)CD34(-) HSC进行移植的大部分小鼠显示出长期的RB6-8C5(+)CD3(+)(淋巴样)重建,但没有RB6-8C5(+)CD3(-)(髓样)重建。最值得注意的是,使用RB6-8C5作为髓系特异性抗体可能具有误导性,因为它暗示存在能够长期重建造血髓系和T细胞谱系但不能重建造血B细胞谱系的谱系限制性HSC。由于“谱系特异性”标志物的跨谱系表达不太可能是血液系统所特有的,因此关于意外细胞命运的说法不仅应通过获得谱系特异性标志物来证实,还应通过缺乏通常源自所研究干细胞的其他谱系的标志物来证实。